Revenue
2013
2014
2015
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.3M | $6.0M | $6.5M | $4.5M | $1.9M | $3.1M | $2.2M | $3.3M | $3.6M | $2.8M | $940,008 |
| Gross profit | $1.3M | $1.3M | $1.1M | $963,501 | $832,255 | $681,568 | $573,530 | $615,867 | $378,503 | $664,508 | $352,260 |
| Research & development | $170,800 | $363,350 | $797,112 | — | — | $264,767 | $304,121 | $285,837 | — | — | — |
| Operating expenses | $4.5M | $5.4M | $5.1M | $4.3M | $3.6M | $4.0M | $5.5M | $7.4M | — | — | — |
| Operating income | −$3.2M | −$4.1M | −$4.0M | −$3.3M | −$2.7M | −$3.3M | −$5.0M | −$6.8M | −$3.8M | −$4.4M | −$1.9M |
| EBITDAderived | −$3.2M | −$4.0M | −$4.0M | −$3.3M | −$2.7M | −$3.1M | −$4.7M | −$6.6M | −$3.6M | −$4.1M | −$1.8M |
| Net income | −$3.2M | −$4.0M | −$4.1M | −$3.3M | −$3.0M | −$3.8M | −$5.7M | −$6.8M | −$3.8M | −$4.5M | −$1.9M |
| Basic EPSper diluted share | -$0.88 | -$1.81 | -$2.07 | -$0.26 | -$0.34 | -$0.14 | -$0.21 | -$0.27 | -$0.20 | -$0.28 | -$0.14 |
| Diluted EPSper diluted share | -$0.88 | -$1.81 | -$2.07 | -$0.26 | -$0.04 | -$0.14 | -$0.21 | -$0.27 | -$0.20 | -$0.28 | -$0.14 |